DrugBiological
Thioridazine clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 5
Technical University of Munich (1) · Ontario Clinical Oncology Group (OCOG) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Hannover Medical School (1) · New Mexico Cancer Research Alliance (1)
Often tested with
Tested in the same studies.
Olanzapine (2) · Amisulpride (2) · Risperidone (2) · Haloperidol (2) · Quetiapine (2) · Perphenazine (2) · Sulpiride (2) · Bromperidol (2)
Related medicines
As reviewed, each with the page that says it.
- One of Antipsychotic Agents source
Studies
Open first, then newest update. How each study uses Thioridazine is read from its arms, and is right about nine times in ten.
Testing it · 5
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsCompletedPhase 4Technical University of MunichNCT02307396Written as Thioridazine
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedPhase 3Hannover Medical SchoolNCT02374567Written as Thioridazine
- Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid LeukemiaCompletedPhase 1Ontario Clinical Oncology Group (OCOG)NCT02096289Written as Thioridazine
- Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor CellsTerminatedEarly Phase 1New Mexico Cancer Research AllianceNCT01765803Written as Mellaril
- Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy AdultsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00118924Written as LGT(TP21)/DEN4
Codes
What other systems call Thioridazine · ClinicalTrials.gg INT008310
- MeSH (NLM) D013881ThioridazineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) N3D6TG58NITHIORIDAZINEConfirmed FDA, NLM, Wikidata
- RxNorm 10502Confirmed FDA, Wikidata
- Wikidata Q58375thioridazineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61971ThioridazineOne source FDA
- DrugBank DB00679One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013881 | Thioridazine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | N3D6TG58NI | THIORIDAZINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 10502 | — | Confirmed FDA, Wikidata |
| Wikidata | Q58375 | thioridazine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61971 | Thioridazine | One source FDA |
| DrugBank | DB00679 | — | One source Wikidata |
Also registered as thioridazine hydrochloride (UNII 4WCI67NK8M · RxNorm 203165).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.